NYSE American - Delayed Quote • USD
Senseonics Holdings, Inc. (SENS)
At close: 4:00 PM EDT
After hours: 4:17 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Timothy T. Goodnow Ph.D. | President, CEO & Director | 1.28M | -- | 1962 |
Dr. Mukul Jain Ph.D. | Chief Operating Officer | 769.17k | -- | 1973 |
Mr. Kenneth L. Horton | General Counsel & Corporate Development Advisor | 737.28k | -- | 1967 |
Mr. Frederick T. Sullivan | CFO, Secretary & Treasurer | -- | -- | 1982 |
Dr. Francine Ratner Kaufman M.D. | Chief Medical Officer & Director | -- | -- | 1951 |
Senseonics Holdings, Inc.
20451 Seneca Meadows Parkway
Germantown, MD 20876-7005
United States
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 132
Description
Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Corporate Governance
Senseonics Holdings, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 10. The pillar scores are Audit: 8; Board: 8; Shareholder Rights: 8; Compensation: 10.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Apr 12, 2024ARS: Annual Report to ShareholdersSee Full Filing
- Mar 25, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Mar 01, 202410-K: Periodic Financial ReportsSee Full Filing
- Feb 29, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Jan 04, 20248-K: Corporate Changes & Voting MattersSee Full Filing
Upcoming Events
May 07, 2024 - May 13, 2024
Senseonics Holdings, Inc. Earnings Call
Related Tickers
ZOM Zomedica Corp.
0.1302
-0.84%
DXCM DexCom, Inc.
137.87
+2.89%
ASXC Asensus Surgical, Inc.
0.2430
-2.41%
TNDM Tandem Diabetes Care, Inc.
35.12
+0.43%
PACB Pacific Biosciences of California, Inc.
1.3600
-7.48%
NNOX Nano-X Imaging Ltd.
9.09
-2.36%
SINT Sintx Technologies, Inc.
0.0387
+8.10%
INVO INVO Bioscience, Inc.
1.1700
-10.00%
BIOL BIOLASE, Inc.
0.1440
-4.70%
CATX Perspective Therapeutics, Inc.
1.6900
-0.59%